News | November 12, 2021
J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
The new products include the COAG Line automated, semi-automated and POC systems manufactured by Diagon Hungary
It is one of the first companies to launch a bioequivalent version of the dry powder inhaler and it's part of the company’s strategic exclusive in-licensing arrangement to market Tiotropium DPI in Western Europe and the UK
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
The acquisition complements and strengthens Merck’s cardiovascular pipeline
Its DirectDetect reagent eliminates RNA extraction for rapid deployment of Covid-19 tests in affected countries
_256_384.jpg)
In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).
In his previous assignment Perfetti was associated with Fabbrica Italiana Sintetici (F.I.S) as Chief Commercial Officer
The company plans to invest in technology, business development, product innovation, and development across India
Substantial reduction in losses
Subscribe To Our Newsletter & Stay Updated
